GWSG
BNGO icon

GPS Wealth Strategies Group’s Bionano Genomics BNGO Stock Holding History

GPS Wealth Strategies Group’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16
Closed -$27 – 672
2025
Q3 		$27 Hold
16
– – ﹤0.01% 1653
2025
Q2 		$52 Hold
16
– – ﹤0.01% 1617
2025
Q1 		$45 Sell
16
-1
-6% -$7 ﹤0.01% 1488
2024
Q4 		$288 Hold
17
– – ﹤0.01% 1343
2024
Q3 		$454 Buy
+17
New +$529 ﹤0.01% 1331

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RS
R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return

GPS Wealth Strategies Group's BNGO Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Bionano Genomics (BNGO) in Q4 2025, closing a stake of 16 shares — an estimated $27 sold.

GPS Wealth Strategies Group first reported a position in BNGO in Q3 2024 and held it in 5 quarters. The position peaked at $454 in Q3 2024. 32 funds tracked by Wall St. Rank hold BNGO as of Q4 2025.

  • GPS Wealth Strategies Group reported no remaining Bionano Genomics position as of Q4 2025 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 16 Bionano Genomics shares in Q4 2025, an estimated $27.
  • GPS Wealth Strategies Group first reported a position in Bionano Genomics in Q3 2024 and held it in 5 quarters.
  • GPS Wealth Strategies Group's Bionano Genomics position peaked at $454 in Q3 2024.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.